Biotech Rebounds on Optimism and Deal Making

Listen to article (2 minutes) Biotech stocks, some of the biggest losers in the selloff, are…

Drug-Price Rules for Seniors Change With Passage of Climate and Health Bill

Drug-pricing rules embedded in the Inflation Reduction Act will trigger the most significant changes in nearly…

Amgen Fights IRS Over $10.7 Billion Tax Bill

Biotech Amgen Inc. is in a pitched battle with the Internal Revenue Service over the company’s…

Starbucks, Uber, CVS to Report Earnings Amid Shrinking Economy

July 30, 2022 10:00 am ET Listen to article (2 minutes) CVS Health Starbucks and Uber…

Drugmakers Hope New Heart Drugs Boost Sales, Revive Market

The once lucrative heart-drug market is now poised to make a comeback, but at the cost…

Pharma has a hiding place during recession

As pharma companies begin reporting earnings next week, investors could be forgiven for paying more attention…

Drug Pricing Debate in Washington Is a Headache for Pharma

Big Pharma loves political deadlocks. In fact, when Congress split, the stocks of pharmaceutical and biotechnology…